1. CUIR at Chulalongkorn University
  2. Faculty and Institute
  3. Faculty of Medicine - Med
  4. Med - Journal Articles
Please use this identifier to cite or link to this item: https://cuir.car.chula.ac.th/handle/123456789/14378
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSuthiluk Patumraj-
dc.contributor.authorPornprom Yoysungneon-
dc.contributor.otherChulalongkorn University. Faculty of Medicine-
dc.contributor.otherNaresuan University. Faculty of Medical Science-
dc.date.accessioned2011-01-06T04:13:17Z-
dc.date.available2011-01-06T04:13:17Z-
dc.date.issued2007-
dc.identifier.citationAsian biomedicine : research, reviews and news. 1,3(October 2007) : 239-252en
dc.identifier.issn1905-7415-
dc.identifier.urihttp://cuir.car.chula.ac.th/handle/123456789/14378-
dc.description.abstractObjective: This article reviews the effect of curcumin against tumor angiogenesis from view-points of cancer microcirculation and biomarkers. Results and conclusion. We demonstrated an anti-angiogenic effect of curcumin in tumors using nude mice. We studied the inhibitory effects of curcumin on tumor-induced neocapillaries and proangiogenic factors, based on our intravital fluorescent observation. Finally, we hypothesized a possible mechanism for curcumin effect in tumor.en
dc.format.extent994212 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoenes
dc.publisherChulalongkorn Universityen
dc.rightsChulalongkorn Universityen
dc.subjectBiochemical markersen
dc.subjectMicrocirculationen
dc.subjectCurcumaen
dc.subjectCancer--Treatmenten
dc.titleCurcumin as a therapeutic agent against canceren
dc.typeArticlees
dc.email.authorSuthiluk.P@Chula.ac.th-
dc.email.authorNo information provided-
dc.subject.keywordAnti-angiogenic effecten
dc.subject.keywordBiomarkeren
dc.subject.keywordNeocapillariesen
dc.subject.keywordNude miceen
Appears in Collections:Med - Journal Articles

Files in This Item:
File Description SizeFormat 
article3.pdf970.91 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.